作者：
Quirin,Hammer [1]
;
Karlo,Perica [2]
;
Rina M,Mbofung [3]
;
Hanna,van Ooijen [4]
;
Karen E,Martin [5]
;
Pouria,Momayyezi [6]
;
Erika,Varady [3]
;
Yijia,Pan [3]
;
Mark,Jelcic [3]
;
Brian,Groff [3]
;
Ramzey,Abujarour [3]
;
Silje Z,Krokeide [5]
;
Tom,Lee [3]
;
Alan,Williams [3]
;
Jode P,Goodridge [3]
;
Bahram,Valamehr [3]
;
Björn,Önfelt [7]
;
Michel,Sadelain [8]
;
Karl-Johan,Malmberg [9]
作者单位：
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: quirin.hammer@ki.se.
[1]
Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Cell Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[2]
Fate Therapeutics, Inc., San Diego, CA, USA.
[3]
Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden.
[4]
Precision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
[5]
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
[6]
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden.
[7]
Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[8]
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Precision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: k.j.malmberg@medisin.uio.no.
[9]
DOI
10.1016/j.stem.2024.06.011
PMID
38981470
发布时间
2024-09-07
换一批
换一批
